SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-003992
Filing Date
2021-02-16
Accepted
2021-02-16 16:30:24
Documents
18
Period of Report
2021-02-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 43102
2 ex4-1.htm EX-4.1 115277
3 ex5-1.htm EX-5.1 16866
4 ex10-1.htm EX-10.1 224268
5 ex99-1.htm EX-99.1 6242
6 ex99-2.htm EX-99.2 13095
7 ex99-3.htm EX-99.3 11794
8 ex5-1_001.jpg GRAPHIC 5190
9 ex5-1_002.jpg GRAPHIC 5190
10 ex99-1_001.jpg GRAPHIC 205501
11 ex99-1_002.jpg GRAPHIC 246453
12 ex99-1_003.jpg GRAPHIC 272101
13 ex99-1_004.jpg GRAPHIC 207898
14 ex99-1_005.jpg GRAPHIC 225783
15 ex99-1_006.jpg GRAPHIC 232519
16 ex99-1_007.jpg GRAPHIC 261032
17 ex99-1_008.jpg GRAPHIC 232402
18 ex99-1_009.jpg GRAPHIC 44241
  Complete submission text file 0001493152-21-003992.txt   3102734
Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

IRS No.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36199 | Film No.: 21639198
SIC: 2834 Pharmaceutical Preparations